JP2008525314A - 胃不全麻痺様症状の治療及び／又は予防剤 - Google Patents

胃不全麻痺様症状の治療及び／又は予防剤 Download PDF

Info

Publication number
JP2008525314A
JP2008525314A JP2007531116A JP2007531116A JP2008525314A JP 2008525314 A JP2008525314 A JP 2008525314A JP 2007531116 A JP2007531116 A JP 2007531116A JP 2007531116 A JP2007531116 A JP 2007531116A JP 2008525314 A JP2008525314 A JP 2008525314A
Authority
JP
Japan
Prior art keywords
gastric
symptoms
patient
paralysis
paresis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2007531116A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008525314A5 (https=
Inventor
修 進士
契典 高梨
辰彦 岩瀬
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of JP2008525314A publication Critical patent/JP2008525314A/ja
Publication of JP2008525314A5 publication Critical patent/JP2008525314A5/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
JP2007531116A 2004-12-28 2005-12-28 胃不全麻痺様症状の治療及び／又は予防剤 Withdrawn JP2008525314A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63929104P 2004-12-28 2004-12-28
PCT/JP2005/024263 WO2006070937A1 (en) 2004-12-28 2005-12-28 Drugs for the treatment and/or prophylaxis of gastroparesis symptom

Publications (2)

Publication Number Publication Date
JP2008525314A true JP2008525314A (ja) 2008-07-17
JP2008525314A5 JP2008525314A5 (https=) 2009-02-12

Family

ID=35985467

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007531116A Withdrawn JP2008525314A (ja) 2004-12-28 2005-12-28 胃不全麻痺様症状の治療及び／又は予防剤

Country Status (5)

Country Link
US (1) US7803779B2 (https=)
EP (1) EP1835920A1 (https=)
JP (1) JP2008525314A (https=)
TW (1) TW200633714A (https=)
WO (1) WO2006070937A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7582611B2 (en) 2005-05-24 2009-09-01 Pfizer Inc. Motilide compounds
EP2054429B1 (en) 2006-09-11 2013-11-06 Tranzyme Pharma, Inc. Macrocyclic antagonists of the motilin receptor for treatment of gastrointestinal dysmotility disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY113693A (en) * 1992-05-26 2002-05-31 Chugai Pharmaceutical Co Ltd Erythromycin derivatives having an enterokinesis stimulating action
CA2399198A1 (en) * 2000-02-18 2001-08-23 Christopher Carreras Motilide compounds
EP1557169A4 (en) * 2002-10-25 2010-09-22 Chugai Pharmaceutical Co Ltd MEANS FOR THE TREATMENT AND / OR PREVENTION OF DYSCHEZIA

Also Published As

Publication number Publication date
WO2006070937A1 (en) 2006-07-06
US20090062219A1 (en) 2009-03-05
EP1835920A1 (en) 2007-09-26
US7803779B2 (en) 2010-09-28
TW200633714A (en) 2006-10-01

Similar Documents

Publication Publication Date Title
CN101600438B (zh) 疼痛疾病治疗剂
EA015382B1 (ru) Применение рофлумиласта для лечения сахарного диабета типа 2
JP2004525179A (ja) ジペプチジルペプチダーゼｉｖ阻害剤でのｉｉ型糖尿病の処置
KR20150013671A (ko) 피라졸 유도체 및 그 의약용도
KR20150046125A (ko) Sglt2 저해약과 항고혈압약의 조합
TW202102209A (zh) 低劑量三重組合調配物
US20250325503A1 (en) New use of n,n-bis-2-mercaptoethyl isophthalamide
UA122974C2 (uk) Комбінований лікарський засіб, який містить канагліфлозин і фентермін, для лікування ожиріння й пов'язаних з ожирінням порушень
CN102639128B (zh) 用于预防糖尿病的磺酰胺
AU2006334731B2 (en) Combination of triazine derivatives and insulin secretion stimulators
TWI710372B (zh) 用於胃輕癱之5-ht4受體激動劑
WO2004002473A1 (ja) 血糖コントロール用医薬組成物
CN110290788A (zh) 氨基甲酸酯化合物用于预防、缓解或治疗双相障碍的用途
JP2008525314A (ja) 胃不全麻痺様症状の治療及び／又は予防剤
BR112021006968A2 (pt) avexitide para o tratamento da hipoglicemia hiperinsulinêmica
TWI668005B (zh) 逼尿肌過度活動伴收縮力降低之改善劑
KR20080028415A (ko) ＰＰＡＲγ 애고니스트를 함유하는 의약 조성물
TWI837197B (zh) 胺基甲酸酯化合物於預防、緩解或治療糖尿病周邊神經病變或化療誘發的周邊神經病變的用途
MX2014014316A (es) Método de reducción de peso.
JP2010529125A (ja) 胃食道逆流疾患の治療に有用な組成物
CN101115483A (zh) 含有FBPase抑制剂的药物组合物
WO2024141073A1 (en) Pharmaceutical combinations and compositions, and methods of use thereof
JP2006519881A5 (https=)
EP1891971A1 (en) Medicinal composition for ameliorating or treating glucose intolerance, borderline diabetes, insulin resistance and hyperinsulinemia containing hypoglycemic agent
US20110245200A1 (en) Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20081217

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20081217

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20110912

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20111214